(BKYI) BIO-Key International - Ratings and Ratios

Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US09060C3097

BKYI: Biometric, Fingerprint, Identification, Security, Software, Solutions

BIO-key International, Inc. (NASDAQ:BKYI) specializes in biometric identification technologies and enterprise-grade identity access management (IAM) solutions. The company serves a diverse range of sectors, including corporate, government, and education, both domestically and internationally. Its flagship product, BIO-key PortalGuard, is a cloud-based IAM platform designed to integrate seamlessly with SaaS applications, on-premises systems, and cloud services. PortalGuard IDaaS extends these capabilities, offering a customer-controlled, neutral-by-design identity platform. These solutions enhance security for workforces, student populations, and partner networks, enabling collaboration while minimizing risks. The company also offers BIO-key VST and WEB-key products, as well as Civil and Large-Scale ID Infrastructure solutions, which leverage fingerprint-based biometric technology for advanced identification needs. Under the SideSwipe, EcoID, and SidePass brands, BIO-key provides finger scanners tailored for both enterprise and consumer markets. Originally founded in 1993 as SAC Technologies, the company rebranded as BIO-key International, Inc. in 2002 and is headquartered in Holmdel, New Jersey.

3-Month Forecast: Based on technical and fundamental data, BIO-key International, Inc. (BKYI) is expected to experience continued volatility. The stock is currently trading at $1.22, with a 20-day average volume of 111,098 shares. The SMA 20 ($1.10) and SMA 50 ($1.37) indicate recent fluctuations, with the stock price oscillating above and below these levels. The SMA 200 ($1.30) suggests a potential resistance level. The ATR of $0.22 signals moderate price movement expectations. Fundamentally, the companys market cap of $3.25M and P/S ratio of 0.54 reflect its micro-cap status and potential sensitivity to market sentiment. Over the next three months, BKYI may face headwinds due to its high P/B ratio (29.40) and lack of profitability (P/E: 0.00). Technical support near $1.00 and resistance around $1.50 are key levels to monitor.

Additional Sources for BKYI Stock

BKYI Stock Overview

Market Cap in USD 4m
Sector Industrials
Industry Security & Protection Services
GiC Sub-Industry Systems Software
IPO / Inception 1997-02-14

BKYI Stock Ratings

Growth Rating -87.6
Fundamental -
Dividend Rating 0.0
Rel. Strength -57.9
Analysts 4/5
Fair Price Momentum 0.29 USD
Fair Price DCF -

BKYI Dividends

No Dividends Paid

BKYI Growth Ratios

Growth Correlation 3m -84%
Growth Correlation 12m -62.8%
Growth Correlation 5y -98.7%
CAGR 5y -65.32%
CAGR/Max DD 5y -0.66
Sharpe Ratio 12m -1.23
Alpha -66.41
Beta 0.989
Volatility 93.05%
Current Volume 53.8k
Average Volume 20d 104.5k
What is the price of BKYI stocks?
As of May 02, 2025, the stock is trading at USD 0.79 with a total of 53,819 shares traded.
Over the past week, the price has changed by +5.61%, over one month by +4.02%, over three months by -36.21% and over the past year by -53.47%.
Is BIO-Key International a good stock to buy?
No, based on ValueRay Analyses, BIO-Key International (NASDAQ:BKYI) is currently (May 2025) a stock to sell. It has a ValueRay Growth Rating of -87.58 and therefor a clear technical negative rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of BKYI as of May 2025 is 0.29. This means that BKYI is currently overvalued and has a potential downside of -63.29%.
Is BKYI a buy, sell or hold?
BIO-Key International has received a consensus analysts rating of 4.00. Therefor, it is recommend to buy BKYI.
  • Strong Buy: 0
  • Buy: 1
  • Hold: 0
  • Sell: 0
  • Strong Sell: 0
What are the forecast for BKYI stock price target?
According to ValueRays Forecast Model, BKYI BIO-Key International will be worth about 0.3 in May 2026. The stock is currently trading at 0.79. This means that the stock has a potential downside of -58.23%.
Issuer Forecast Upside
Wallstreet Target Price 3 279.7%
Analysts Target Price 3 279.7%
ValueRay Target Price 0.3 -58.2%